The impact of medication resistance and continuation pharmacotherapy on relapse following response to electroconvulsive therapy in major depression

Journal of Clinical Psychopharmacology

Volumn 10, Issue 2, 1990, Pages 96-104

  Sackeim, Harold A ^a,b   Prudic, Joan ^a,b   Devanand, D P ^a,b   Decina, Paolo ^a,b   Kerr, Barbara ^a   Malitz, Sidney ^a,b  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT;

ADULT; AGED; ARTICLE; DEPRESSION; DRUG RESISTANCE; ELECTROCONVULSIVE THERAPY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT;

AGED; ANTIDEPRESSIVE AGENTS, TRICYCLIC; DEPRESSIVE DISORDER; DRUG RESISTANCE; ELECTROCONVULSIVE THERAPY; FEMALE; HUMAN; MALE; MIDDLE AGE; MONITORING, PHYSIOLOGIC; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RECURRENCE; SUPPORT, U.S. GOV'T, P.H.S.; SURVIVAL ANALYSIS;

EID: 0025215518     PISSN: 02710749     EISSN: 1533712X     Source Type: Journal    
DOI: 10.1097/00004714-199004000-00004     Document Type: Article

References (40)

1. Mindham RHS, Howland C, Shepherd M. An evaluation of continuation therapy with tricyclic antidepressants in depressive illness. Psychol Med 1973;3:5-17.
2. Prien RF, Klett CJ, Caffey EM Jr. Lithium carbonate and imipramine in prevention of affective episodes: a comparison in recurrent affective illness. Arch Gen Psychiatry 1973;29:420-5.
3. Klein D, Gittelman R, Quitkin F, Rifkin A. Diagnosis and drug treatment of psychiatric disorders: adults and children. Baltimore: Williams & Wilkins, 1980.
4. Imlah NW, Ryan E, Harrington JA. The influence of antidepressant drugs on the response to electroconvultsive therapy and on subsequent relapse rates. Neuropsychopharmacology 1965;4:438-42.
5. Kay DWK, Kahy T, Garside RF. A 7-month double-blind trial of amitriptyline and diazepam in ECT-treated depressed patients. Br J Psychiatry 1970;117:667-71.
6. Seager CR, Bird RL. Imipramine with electrical treatment in depression—a controlled trial. J Ment Sci 1962;108:704-7.
7. Snaith RP. How much ECT does the depressed patient need? In: Palmer RL, ed. Electroconvulsive therapy: an appraisal. New York: Oxford University Press, 1981:61-4.
8. Frankel FH, Bidder TG, Fink M, Mandel MR, Small IF, Wayne GJ, Squire LR, Dutton EN, Gurel L. Electroconvulsive therapy: report of the Task Force on Electroconvulsive Therapy of the American Psychiatric Association. Washington, DC: American Psychiatric Association, 1978.
9. Endicott J, Spitzer RL. A diagnostic interview: the Schedule for Affective Disorders and Schizophrenia. Arch Gen Psychiatry 1978;35:837-44.
10. Spitzer RL, Endicott J, Robins E. Research diagnostic criteria: rationale and reliability. Arch Gen Psychiatry 1978;35:773-82.
11. Sackeim HA, Decina P, Kanzler M, Kerr B, Malitz S. Effects of electrode placement on the efficacy of titrated, low-dose ECT. Am J Psychiatry 1987;144:1449-55.
12. Sackeim HA, Decina P, Prohovnik I, Malitz S. Seizure threshold in electroconvulsive therapy: effects of sex, age, electrode placement, and treatment numoer. Arch Gen Psychiatry 1987;44:355-60.
13. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967;6:278-96.
14. Hamilton M. The effect of treatment on the melancholias (depressions). Br J Psychiatry 1982;140:223-30.
15. Keller M, Lavori P, Endicott J, Coryell W, Klerman G. “Double depression”: two-year follow-up. Am J Psychiatry 1983;140:689-94.
16. Spiker DG, Weiss JC, Dealy RS, Griffin SJ, Hanin I, Nei1 JF, Perel JM, Rossi AJ, Soloff PH. The pharmacological treatment of delusional depression. Am J Psychiatry 1985;142:430-6.
17. Keller MB, Lavori PW, Klerman GL, Andreasen NC, Endicott J, Coryell W, Fawcett J, Rice JP, Hirschfeld RMA. Low levels and lack of predictors of somatotherapy and psychotherapy received by depressed patients. Arch Gen Psychiatry 1986;43:458-66.
18. SAS User’s Guide. Statistics, Version 5 edition. Cary, NC: SAS Institute, 1985.
19. Cox DR, Oakes D. Analysis of survival data. London: Chapman and Hall, 1984.
20. Coppen A, Abou-Saleh MT, Milln P, Bailey J, Metcalfe M, Burns BH, Arnold A. Lithium continuation therapy following electroconvulsive therapy. Br J Psychiatry 1981;139:284-7.
21. Perry P, Tsuang MT. Treatment of unipolar depression following electroconvulsive therapy: relapse rate comparisons between lithium and tricyclics therapies following ECT. J Affective Disord 1979;1:123-9.
22. Klerman GL, DiMascio A, Weissman M, Prusoff B, Paykel ES. Treatment of depression by drugs and psychotherapy. Am J Psychiatry 1974;131:186-91.
23. Sackeim HA, Portnoy S, Neeley P, Steif BL, Decina P, Malitz S. Cognitive consequences of low dosage ECT. Ann NY Acad Sci 1986;462:326-40.
24. Squire LR. Memory functions as affected by electroconvulsive therapy. Ann NY Acad Sci 1986;462:307-14.
25. Weiner RD. Does electroconvulsive therapy cause brain damage? Behav Brain Sci 1984;7:1-54.
26. Silfverskiold P, Gustafson L, Johanson A, Risberg J, Rosen I. Acute and late effects on rCBF, EEG, psychometric testing and clinical outcome. Ann NY Acad Sci 1986;462:236-48.
27. Aronson TA, Shukla S, Hoff A. Continuation therapy after ECT for delusional depression: a naturalistic study of prophylatic treatments and relapse. Convulsive Ther 1987;3:251-9.
28. Spiker DG, Stein J, Rich CL. Delusional depression and electroconvulsive therapy: one year later. Convulsive Ther 1985;1:167-72.
29. Fink M. Convulsive therapy: theory and practice. New York: Raven Press, 1979.
30. Sackeim HA. The efficacy of ECT. Ann NY Acad Sci 1986;462:70-5.
31. Quitkin FM, Rabkin JG, Ross D, McGrath PJ. Duration of antidepressant drug treatment: what is an adequate trial? Arch Gen Psychiatry 1984;41:238-45.
32. Abou-Saleh MT. How long should drug therapy for depression be maintained? Am J Psychiatry 1987;144:1247-8.
33. Bourne H. Convulsion dependence. Lancet 1954;2:1193-6.
34. Decina P, Guthrie EB, Sackeim HA, Kahn D, Malitz S. Continuation ECT in the management of relapses of major affective episodes. Acta Psychiatr Scand 1987;75:559-62.
35. Stevenson GH, Geoghegan JJ. Prophylatic electroshock: a five-year study. Am J Psychiatry 1951;107:743-8.
36. Kramer BA. Maintenance ECT: a survey of practice (1986). Convulsive Ther 1987;3:260-8.
37. Sackeim HA, Decina P, Prohovnik I, Malitz S, Resor S. Anticonvulsant and antidepressant properties of ECT: a proposed mechanism of action. Biol Psychiatry 1983;18:1301-10.
38. Sackeim HA, Decina P, Prohovnik I, Portnoy, S, Malitz S. Dosage, seizure threshold, and efficacy. Ann NY Acad Sci 1986;462:398-410.
39. Lloyd KG, Morselli PL, Bartholini G. GABA and affective disorders. Med Biol 1987;65:159-65.
40. Morselli PL, Fournier V, Nacker JP, Orofiama B, Bottin P, Huber JP. Therapeutic action of progabide in depressive illness: a controlled clinical trial. In: Bartholini G, Lloyd KG, Morselli PL, eds. GABA and mood disorders. New York: Raven Press, 1986.